What do my test results mean?
Burford DC, Kirby M, Austoker J. Prostate Cancer Risk Management
Programme: information for primary care; PSA testing in
asymptomatic men. NHS Cancer Screening Programmes, 2009.
Holmstrom B, Johansson M, Bergh A et al. Prostate specific
antigen for early detection of prostate cancer: longitudinal study.
BMJ 2009;339:b3537
Heidenreich A, Bolla M, Joniau S et al. Guidelines on prostate
cancer. European Association of Urology. 2011.
National Institute for Health and Clinical Excellence. Prostate
cancer: diagnosis and treatment. Full guideline. 2008.
What are my treatment options?
National Institute for Health and Clinical Excellence. Prostate
cancer: diagnosis and treatment. Full guideline. 2008.
Payne H. Management of locally advanced prostate cancer. Asian
Journal of Andrology. 2009;11:81-87.
National Institute for Health and Clinical Excellence. Low dose
rate brachytherapy for localised
prostate cancer. Interventional Procedure Guidance 132. 2005
National Institute for Health and Clinical Excellence. High dose
rate brachytherapy in combination with external-beam radiotherapy
for localised prostate cancer. Interventional Procedure Guidance
174. 2006
Al-Salihi O, Mitra A, Payne H. Challenge of dose escalation in
locally advanced unfavourable prostate cancer using HDR
brachytherapy. Prostate Cancer Prostatic Dis. 2006;9(4):370-3.